HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Clinical trial NCT05623189 · COMPLETED

Trial details

NCT number: NCT05623189
Sponsor: HighTide Therapeutics (Hong Kong) Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes

Start date: 2022-12-27
Primary completion: 2025-03-31
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.